Shots:

• The US FDA has issued a EUA for the Elecsys IL-6 test which measures levels of the biomarker IL-6 and can be used to identify patients with confirmed COVID-19 disease with a high risk of intubation with mechanical ventilation
• The test allows the physician to decide early if a patient with confirmed COVID-19 illness requires mechanical ventilation
• The test will be available in the countries accepting CE mark and will run on Roche’s Cobas e analyzers- widely available across the globe. These fully automated systems can provide test results in ~18 minutes- with a test throughput of up to 300 tests/hour- depending on the analyzer

Click here ­to­ read full press release/ article 

Ref: Roche | Image: Roche